1-3 of 3
Jean-François Meritet
Close
Sort by
Journal Articles

Results from the Completed Hgb-205 Trial of Lentiglobin for β-Thalassemia and Lentiglobin for Sickle Cell Disease Gene Therapy

Elisa Magrin, PhD, Michaela Semeraro, MD PhD, Alessandra Magnani, MD PhD, Hervé Puy, MD PhD, Annarita Miccio, PhD, Nicolas Hebert, Jean-Sebastien Diana, MD, Francois Lefrere, MD, Felipe Suarez, MD PhD, Olivier Hermine, MD PhD, Valentine Brousse, MD, Catherine Poirot, MD PhD, Philippe Bourget, PharmD, PhD, Wassim El Nemer, PhD, Isabelle Guichard, MD, Despina Moshous, MD PhD, Benedicte Neven, MD, Fabrice Monpoux, MD, Marilyne Poirée, MD, Pablo Bartolucci, MD PhD, Jean-François Meritet, MD, David Grévent, MD, Thibaud Lefebvre, Pharm D.,PhD, Mohammed Asmal, MD PhD, Erin Whitney, MBA, Marisa Gayron, MS, Wenmei Huang, PhD MS, Isabelle Funck-Brentano, PsyD, Mariane de Montalembert, MD PhD, Laure Joseph, MD, Jean-Antoine Ribeil, MD PhD, Marina Cavazzana
Journal: Blood
Blood (2019) 134 (Supplement_1): 3358.
https://doi.org/10.1182/blood-2019-127393
Published: 2019
Journal Articles

Longer Term Follow-up on the First Patients with Severe Hemoglobinopathies Treated with Lentiglobin Gene Therapy

Marina Cavazzana, MD PhD, Salima Hacein-Bey-Abina, Pharm.D.,PhD, Emmanuel Payen, Elisa Magrin, PhD, Alessandra Magnani, MD PhD, Michaela Semeraro, Laure Caccavelli, Fabien Touzot, MD PhD, Francois Lefrere, Sr., Felipe Suarez, MDPhD, Olivier Hermine, Valentine Brousse, MD, Catherine Poirot, Despina Moshous, Philippe Bourget, PhD, Wassim El Nemer, PhD, Pablo Bartolucci, MD PhD, Leslie Weber, Herve Puy, MD, Jean-François Meritet, David Grévent, MD, Yves Beuzard, MD, Stany Chretien, Thibaud Lefebvre, Mohammed Asmal, MD PhD, Alexandra Laura Miller, Mariane De Montalembert, MD PhD, Stephane Blanche, MD, Philippe Leboulch, MD, Jean-Antoine Ribeil, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4609.
https://doi.org/10.1182/blood.V130.Suppl_1.4609.4609
Published: 2017
Journal Articles

Update from the Hgb-205 Phase 1/2 Clinical Study of Lentiglobin Gene Therapy: Sustained Clinical Benefit in Severe Hemoglobinopathies

Jean-Antoine Ribeil, MD PhD, Salima Hacein-Bey-Abina, Pharm.D., PhD, Emmanuel Payen, PhD, Michaela Semeraro, PhD, Magrin Elisa, PhD, Laure Caccavelli, PhD, Fabien Touzot, MD PhD, Francois Lefrere, MD, Felipe Suarez, MD PhD, Olivier Hermine, MD PhD, Valentine Brousse, MD, Catherine Poirot, MD PhD, Benedicte Neven, MD PhD, Philippe Bourget, PharmD, PhD, Wassim El Nemer, PhD, Pablo Bartolucci, MD PhD, Leslie Weber, MSc, Hervé Puy, MD PhD, Jean-François Méritet, PhD, David Grevent, MD, Yves Beuzard, MD, Stany Chrétien, MD, Thibaud Lefebvre, MD, Mohammed Asmal, MD PhD, Marcelyne Joseney-Antoine, Mariane De Montalembert, MD PhD, Stephane Blanche, MD, Philippe Leboulch, MD, Marina Cavazzana, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2311.
https://doi.org/10.1182/blood.V128.22.2311.2311
Published: 2016